Pharmion, Lipomed thalidomide deal

Lipomed (Arlesheim, Switzerland) received exclusive rights from PHRM to distribute Thalidomide Pharmion 50 mg in Switzerland and Austria. Lipomend also will distribute PHRM's Refludan, a recombinant hirudin to treat thrombosis associated with the severe form of heparin-associated thrombocytopenia (HAT) Type II, and myelodysplastic syndrome drug Vidaza azacitidine.

In addition, Lipomed will stop selling its own formulation of thalidomide in Austria, Switzerland and all other EU markets, and the parties agreed to terminate ongoing patent infringement litigation that PHRM brought against Lipomed last fall. ...